ĐẶC ĐIỂM LÂM SÀNG SẸO LỒI, SẸO PHÌ ĐẠI TRÊN BỆNH NHÂN ĐIỀU TRỊ SẸO BẰNG TIÊM TRIAMCINOLONE

Abstract

Background: Keloids, hypertrophic scars can cause aesthetically disfiguring, functionally debilitating, emotionally distressing, and psychologically damaging; therefore, them reducing the life quality of patients. The clinical characteristics may affect the result of triamcinolone intralesional treatment. Objectives: Describe clinical characteristics of keloids, hypertrophic scars of patients treated with triamcinolone intralesional injection at Can Tho University of Medicine and Pharmacy Hospital and Can Tho Dermato-Venereology Hospital 2019-2021. Materials and methods: Cross-sectional descriptive study was carried out on 80 patients with keloids, hypertrophic scars at Can Tho University of Medicine and Pharmacy Hospital and Can Tho Dermato-Venereology Hospital in 2019-2021. Results: The main causations of scarring were spontaneous 48.83%, acne 23.26% and skin injuries 24.03%. Most scars have a duration of  ≥ 1 year, the most common locations were the chest and pre-sternum. The scar area ranged from 0.4 to 20cm², with median of 2cm². The rate of pain and the mean VSS score were higher in patients with ≥ 5cm² scar (p < 0.001). Conclusion: Most of the scars were small, spontaneous, ≥ 1 year, located in the chest and pre-sternum. The rate of pain and the mean VSS score were relative to the scar area (p < 0.001).